In humans, levels of FTO mRNA and protein are elevated in the liver of nonalcoholic fatty liver disease (NAFLD) patients who are also hyperglycemic and hyperinsulinemic compared to healthy control subjects [37]. This evidence concerns the gene FTO and metabolic dysfunction-associated steatotic liver disease.